Cargando…
Granulocyte-Macrophage Colony-Stimulating Factor Modulates Myeloid-Derived Suppressor Cells and Treg Activity in Decompensated Cirrhotic Patients With Sepsis
BACKGROUND: Decompensated cirrhosis patients are more prone to bacterial infections. Myeloid-derived suppressor cells (MDSCs) expand in sepsis patients and disrupt immune cell functions. Granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy helps in restoring immune cell functions and re...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205181/ https://www.ncbi.nlm.nih.gov/pubmed/35720398 http://dx.doi.org/10.3389/fimmu.2022.828949 |
_version_ | 1784729073978703872 |
---|---|
author | Sehgal, Rashi Maiwall, Rakhi Rajan, Vijayaraghavan Islam, Mojahidul Baweja, Sukriti Kaur, Navkiran Kumar, Guresh Ramakrishna, Gayatri Sarin, Shiv K. Trehanpati, Nirupma |
author_facet | Sehgal, Rashi Maiwall, Rakhi Rajan, Vijayaraghavan Islam, Mojahidul Baweja, Sukriti Kaur, Navkiran Kumar, Guresh Ramakrishna, Gayatri Sarin, Shiv K. Trehanpati, Nirupma |
author_sort | Sehgal, Rashi |
collection | PubMed |
description | BACKGROUND: Decompensated cirrhosis patients are more prone to bacterial infections. Myeloid-derived suppressor cells (MDSCs) expand in sepsis patients and disrupt immune cell functions. Granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy helps in restoring immune cell functions and resolving infections. Its role in MDSC modulation in cirrhosis with sepsis is not well understood. METHODS: A total of 164 decompensated cirrhotic—62 without (w/o), 72 with sepsis, and 30 with sepsis treated with GM-CSF—and 15 healthy were studied. High-dimensional flow cytometry was performed to analyze MDSCs, monocytes, neutrophils, CD4 T cells, and Tregs at admission and on days 3 and day 7. Ex vivo co-cultured MDSCs with T cells were assessed for proliferation and apoptosis of T cells and differentiation to Tregs. Plasma factors and mRNA levels were analyzed by cytokine-bead assay and qRT-PCR. RESULTS: Frequencies of MDSCs and Tregs were significantly increased (p = 0.011 and p = 0.02) with decreased CD4 T cells (p = 0.01) in sepsis than w/o sepsis and healthy controls (HCs) (p = 0.000, p = 0.07, and p = 0.01) at day 0 and day 7. In sepsis patients, MDSCs had increased IL-10, Arg1, and iNOS mRNA levels (p = 0.016, p = 0.043, and p = 0.045). Ex vivo co-cultured MDSCs with T cells drove T-cell apoptosis (p = 0.03, p = 0.03) with decreased T-cell proliferation and enhanced FOXP3(+) expression (p = 0.044 and p = 0.043) in sepsis compared to w/o sepsis at day 0. Moreover, blocking the MDSCs with inhibitors suppressed FOXP3 expression. GM-CSF treatment in sepsis patients significantly decreased MDSCs and FOXP3(+) Tregs but increased CD4 T-cell functionality and improved survival. CONCLUSION: MDSCs have an immunosuppressive function by expanding FOXP3(+) Tregs and inhibiting CD4(+) T-cell proliferation in sepsis. GM-CSF treatment suppressed MDSCs, improved T-cell functionality, and reduced Tregs in circulation. |
format | Online Article Text |
id | pubmed-9205181 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92051812022-06-18 Granulocyte-Macrophage Colony-Stimulating Factor Modulates Myeloid-Derived Suppressor Cells and Treg Activity in Decompensated Cirrhotic Patients With Sepsis Sehgal, Rashi Maiwall, Rakhi Rajan, Vijayaraghavan Islam, Mojahidul Baweja, Sukriti Kaur, Navkiran Kumar, Guresh Ramakrishna, Gayatri Sarin, Shiv K. Trehanpati, Nirupma Front Immunol Immunology BACKGROUND: Decompensated cirrhosis patients are more prone to bacterial infections. Myeloid-derived suppressor cells (MDSCs) expand in sepsis patients and disrupt immune cell functions. Granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy helps in restoring immune cell functions and resolving infections. Its role in MDSC modulation in cirrhosis with sepsis is not well understood. METHODS: A total of 164 decompensated cirrhotic—62 without (w/o), 72 with sepsis, and 30 with sepsis treated with GM-CSF—and 15 healthy were studied. High-dimensional flow cytometry was performed to analyze MDSCs, monocytes, neutrophils, CD4 T cells, and Tregs at admission and on days 3 and day 7. Ex vivo co-cultured MDSCs with T cells were assessed for proliferation and apoptosis of T cells and differentiation to Tregs. Plasma factors and mRNA levels were analyzed by cytokine-bead assay and qRT-PCR. RESULTS: Frequencies of MDSCs and Tregs were significantly increased (p = 0.011 and p = 0.02) with decreased CD4 T cells (p = 0.01) in sepsis than w/o sepsis and healthy controls (HCs) (p = 0.000, p = 0.07, and p = 0.01) at day 0 and day 7. In sepsis patients, MDSCs had increased IL-10, Arg1, and iNOS mRNA levels (p = 0.016, p = 0.043, and p = 0.045). Ex vivo co-cultured MDSCs with T cells drove T-cell apoptosis (p = 0.03, p = 0.03) with decreased T-cell proliferation and enhanced FOXP3(+) expression (p = 0.044 and p = 0.043) in sepsis compared to w/o sepsis at day 0. Moreover, blocking the MDSCs with inhibitors suppressed FOXP3 expression. GM-CSF treatment in sepsis patients significantly decreased MDSCs and FOXP3(+) Tregs but increased CD4 T-cell functionality and improved survival. CONCLUSION: MDSCs have an immunosuppressive function by expanding FOXP3(+) Tregs and inhibiting CD4(+) T-cell proliferation in sepsis. GM-CSF treatment suppressed MDSCs, improved T-cell functionality, and reduced Tregs in circulation. Frontiers Media S.A. 2022-06-03 /pmc/articles/PMC9205181/ /pubmed/35720398 http://dx.doi.org/10.3389/fimmu.2022.828949 Text en Copyright © 2022 Sehgal, Maiwall, Rajan, Islam, Baweja, Kaur, Kumar, Ramakrishna, Sarin and Trehanpati https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Sehgal, Rashi Maiwall, Rakhi Rajan, Vijayaraghavan Islam, Mojahidul Baweja, Sukriti Kaur, Navkiran Kumar, Guresh Ramakrishna, Gayatri Sarin, Shiv K. Trehanpati, Nirupma Granulocyte-Macrophage Colony-Stimulating Factor Modulates Myeloid-Derived Suppressor Cells and Treg Activity in Decompensated Cirrhotic Patients With Sepsis |
title | Granulocyte-Macrophage Colony-Stimulating Factor Modulates Myeloid-Derived Suppressor Cells and Treg Activity in Decompensated Cirrhotic Patients With Sepsis |
title_full | Granulocyte-Macrophage Colony-Stimulating Factor Modulates Myeloid-Derived Suppressor Cells and Treg Activity in Decompensated Cirrhotic Patients With Sepsis |
title_fullStr | Granulocyte-Macrophage Colony-Stimulating Factor Modulates Myeloid-Derived Suppressor Cells and Treg Activity in Decompensated Cirrhotic Patients With Sepsis |
title_full_unstemmed | Granulocyte-Macrophage Colony-Stimulating Factor Modulates Myeloid-Derived Suppressor Cells and Treg Activity in Decompensated Cirrhotic Patients With Sepsis |
title_short | Granulocyte-Macrophage Colony-Stimulating Factor Modulates Myeloid-Derived Suppressor Cells and Treg Activity in Decompensated Cirrhotic Patients With Sepsis |
title_sort | granulocyte-macrophage colony-stimulating factor modulates myeloid-derived suppressor cells and treg activity in decompensated cirrhotic patients with sepsis |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205181/ https://www.ncbi.nlm.nih.gov/pubmed/35720398 http://dx.doi.org/10.3389/fimmu.2022.828949 |
work_keys_str_mv | AT sehgalrashi granulocytemacrophagecolonystimulatingfactormodulatesmyeloidderivedsuppressorcellsandtregactivityindecompensatedcirrhoticpatientswithsepsis AT maiwallrakhi granulocytemacrophagecolonystimulatingfactormodulatesmyeloidderivedsuppressorcellsandtregactivityindecompensatedcirrhoticpatientswithsepsis AT rajanvijayaraghavan granulocytemacrophagecolonystimulatingfactormodulatesmyeloidderivedsuppressorcellsandtregactivityindecompensatedcirrhoticpatientswithsepsis AT islammojahidul granulocytemacrophagecolonystimulatingfactormodulatesmyeloidderivedsuppressorcellsandtregactivityindecompensatedcirrhoticpatientswithsepsis AT bawejasukriti granulocytemacrophagecolonystimulatingfactormodulatesmyeloidderivedsuppressorcellsandtregactivityindecompensatedcirrhoticpatientswithsepsis AT kaurnavkiran granulocytemacrophagecolonystimulatingfactormodulatesmyeloidderivedsuppressorcellsandtregactivityindecompensatedcirrhoticpatientswithsepsis AT kumarguresh granulocytemacrophagecolonystimulatingfactormodulatesmyeloidderivedsuppressorcellsandtregactivityindecompensatedcirrhoticpatientswithsepsis AT ramakrishnagayatri granulocytemacrophagecolonystimulatingfactormodulatesmyeloidderivedsuppressorcellsandtregactivityindecompensatedcirrhoticpatientswithsepsis AT sarinshivk granulocytemacrophagecolonystimulatingfactormodulatesmyeloidderivedsuppressorcellsandtregactivityindecompensatedcirrhoticpatientswithsepsis AT trehanpatinirupma granulocytemacrophagecolonystimulatingfactormodulatesmyeloidderivedsuppressorcellsandtregactivityindecompensatedcirrhoticpatientswithsepsis |